ATTGENO AB
556692-7751ActiveDeveloping targeted nitric oxide delivery drugs for critical care applications.
Biotechnology Companyattgeno.com
Yleiskatsaus
- 1–4
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2005
- Perustettu
Kuvaus
Attgeno is a Swedish biotechnology company focused on saving patient lives through advanced drug delivery systems. Their core mission revolves around the targeted delivery of nitric oxide (NO), a vital molecule in various physiological processes. The company is pioneering the third generation of NO...
Tunnisteet
B2BPharmaceuticalsTechnology
Avainsanat
Biotechnology